Introduction: Delirium, a serious condition observed in critically ill patients, clinically presents with impaired cognition and consciousness. The relationship between delirium and peripheral levels of insulin growth factor-1 (IGF-1) is unclear. Thus we conducted a meta-analysis to address this issue.
3
Abstract:
Introduction: Delirium, a serious condition observed in critically ill patients, clinically presents with impaired cognition and consciousness. The relationship between delirium and peripheral levels of insulin growth factor-1 (IGF-1) is unclear. Thus we conducted a meta-analysis to address this issue.
Methods: Seven major electronic databases were searched from inception until October 2, 2017 to obtain relevant clinical variables to compare the difference in IGF-1 levels between delirious and non-delirious elderly in-patients. A random effects meta-analysis was conducted.
Results: We studies 10 articles involving 294 delirious patients (mean age 73.0 years) and 604 non-delirious patients (mean age 76.9 years). We found that peripheral levels of IGF-1 in patients with delirium were significantly lower than in those without delirium (Hedges` g = -0.209, 95% confidence interval [CI] = -0.393 to -0.026, p = 0.025). Meta-regression analyses found that no variables such as percentage of cognitive impairment, mean age, and female proportion contribute to heterogeneity in terms of the entire population.
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Introduction
Delirium, which clinically presents with impairment in cognition, consciousness, psychomotor behavior, and attention (Ely et al., 2001) , may manifest with a wide range of subtypes ranging between hyperactive and hypoactive conditions (Steiner, 2011) . Clinically, it usually presents with a sudden onset, which then fluctuates between hours and days and is generally a reversible condition (Yudofsky & Hales, 2008) . Etiologically, delirium indicates an organic decline in cerebral function resulting from variable mechanisms. For example, the etiology of alcohol-withdrawal delirium differs from that causing postoperative delirium (Steiner, 2011) . Incidence of delirium varies depending on the purpose of investigation. Incidence of delirium varies between 9% and 43% among geriatric patients hospitalized for variable medical conditions (Laurila, Pitkala, Strandberg, & Tilvis, 2002; O'Keeffe & Gosney, 1997) . Delirium is commonly observed in elderly patients post surgery, and the incidence of postoperative delirium (POD) ranges widely between 10% and 65% (Radtke et al., 2010; Rudolph & Marcantonio, 2011) . Delirium is a serious neuropsychiatric condition with a substantial impact owing to increased morbidity and mortality, high healthcare costs and prolonged hospitalization associated with it (Hustey, Meldon, Smith, & Lex, 2003; Meagher et al., 2007) . Regarding mortality rates, reportedly, delirious patients show an overall hazard ratio of 1.9 in elderly 6 patients in a meta-analysis study (Witlox et al., 2010) . Given the inadequate understanding of its multifactorial aetiopathogenesis (Hughes, Patel, & Pandharipande, 2012) , researchers are interested in studying the etiology of delirium to better predict its course and prognosis in clinical settings. Although previous reviews (Khan, Zawahiri, Campbell, & Boustani, 2011) have demonstrated the limited role of biomarkers in detection of delirium, researchers have been trying to identify specific biomarkers linked to this condition such as insulin growth factor-1 (IGF-1).
IGF-1 is a member of the IGF family with 70 amino acid peptides, and is primarily produced in the central nervous system (CNS) and peripheral tissues such as the liver (Le Roith, 2003; Torres-Aleman, 2010) . IGF-1 in the CNS plays a vital role in enhancing neuronal survival, differentiation, synaptogenesis, and recovery from neural injury (D'Ercole, Ye, & O'Kusky, 2002) . IGF-I blocks apoptosis in damaged neurons via several mechanisms, such as delay of apoptosis via activation of PI3K/Akt kinase and Ras/Raf/MEK/ERK pathways and results in long-term survival (Gluckman et al., 1998; Parrizas & LeRoith, 1997; Peruzzi et al., 1999) . Clinically, studies have explored its neuroprotective role and association with neurocognitive disorders such as Alzheimer's disease (AD), of which is involved with delirium (Kooijman, Sarre, Michotte, & De Keyser, 2009; Lackey, Gray, & Henricks, 2000) .
Additionally, IGF-1 deficiency in humans may cause growth abnormalities, including   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 7 a smaller sized brain and mental retardation (Werner & LeRoith, 2014) . Furthermore, it has been reported that serum IGF-1 levels positively correlate with cognitive performance in healthy elderly subjects (Al-Delaimy, von Muhlen, & Barrett-Connor, 2009; Aleman et al., 2000) .
Moreover, as researchers keenly investigating the association between peripheral levels of IGF-1 and delirium, several studies have explored the significance of this correlation in patients undergoing surgery or those with acute medical illnesses (Adamis et al., 2009; Cerejeira, Batista, Nogueira, Vaz-Serra, & Mukaetova-Ladinska, 2013; Egberts et al., 2015; Lemstra, Kalisvaart, Vreeswijk, van Gool, & Eikelenboom, 2008; Morandi et al., 2011; Wilson, Broadhurst, Diver, Jackson, & Mottram, 2005) . While some studies report that lower peripheral levels of IGF-I could significantly increase the incidence of delirium (Cerejeira et al., 2013; Egberts et al., 2015; Morandi et al., 2011; Wilson et al., 2005) , the opposite findings have also been reported by some others (Adamis et al., 2009; Lemstra et al., 2008) . Possible factors accounting for this discrepancy are inconsistency between recruited patients, such as postoperative or medically ill cases in terms of study designs or clinical status. Thus, the association between peripheral levels of IGF-I and incidence of delirium in a clinical setting needs to be further studied. Given these aforementioned gaps existing in literature, we performed a 8 comprehensive systematic review and meta-analysis investigating the association between peripheral levels of IGF-1 and delirium, specifically focusing on clinical status of patients. In addition to exploring the difference in this association between surgical or medically ill patients, we also attempted to determine possible factors affecting the correlation between delirium and IGF-1 levels.
Materials and methods
Our systematic review and meta-analysis was based on Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines (Stroup et al., 2000) (supplemental table S1) and was approved by the Institutional Review Board of the Tri-Service General Hospital (TSGHIRB: B-105-12). Two investigators (DJ Li and CS Chu) independently performed database searches, study selection, data extraction, and rating of the methodological quality of included studies. Disagreements between investigators were resolved thorough consensus. figure S1 .
Database searches

Eligibility Criteria and Study Selection
Eligibility criteria applied were: (1) 
Methodological Quality Assessment
The modified Newcastle-Ottawa Scale (NOS) was used to rate methodological quality of included studies (Wells GA). This scale considers three domains: selection of participants (maximum of four stars), comparability of groups (maximum of two stars), and measurement (maximum of three stars). Scores ranged from 0 (the lowest) to 9 (the highest), and a score equal to 7 indicated high methodological quality.
Data Extraction
A predetermined data extraction list was used to extract data for this meta-analysis.
To be specific, the extracted data included basic characteristics of participants (mean age and percentage of female), mini-mental status examination (MMSE), and duration of hospitalization.
Meta-analysis
The primary outcomes were the difference in peripheral IGF-1 levels in delirious patients compared to control groups who did not develop delirium in each recruited ORs into ES using the formula suggested by the Cochrane Handbook (Higgins & Green, 2011) and derived ES using other statistical parameters such as the t or p value with the sample size when raw data were not available via email inquiry. We defined an ES and Hedges' g less than 0 as "lower peripheral IGF-1 levels in patients with delirium than in controls without delirium". Statistical significance was set as a two-tailed p value < 0.05. All meta-analytical procedures were performed using the Comprehensive Meta-Analysis version 3 (CMA ver. 3.0) (Biostat, Englewood, NJ)
software. Meta-analyses were performed using random-effects models due to the anticipated heterogeneity across studies. Briefly, random-effects modeling is more stringent and therefore more convincing than fixed-effects modeling and incorporates a between-study variance in the calculations (Borenstein, Hedges, Higgins, & 12 Rothstein, 2010).
Heterogeneity, publication bias, sensitivity test, and meta-regression
We used the Cochran's Q test and the corresponding p value to investigate potential heterogeneity among recruited studies (Higgins & Thompson, 2002) . The I 2 metric was used to investigate the proportion of variance between recruited studies (Borenstein, Higgins, Hedges, & Rothstein, 2017) . The publication bias was determined by visual examination of funnel plots in situations of less than 10 studies (Higgins & Green, 2011) and using thorough Egger's regression analysis if there were more than 10 studies (Egger, Davey Smith, Schneider, & Minder, 1997) . In situation of significant publication bias, we arranged Duval and Tweedie`s trim and fill test to adjust the results of meta-analysis (Duval & Tweedie, 2000) . Additionally, we performed sensitivity testing with one study removal test to investigate potential confounding by any one of the outlier in the recruited studies, which had been widely used in meta-analysis (Tobias, 1999) . Additionally, we performed meta-regression analysis using an unrestricted maximum likelihood method to explore potential moderators. Variables considered for meta-regression analyses were: mean age, female gender (%), MMSE score, and a total modified NOS scores. The meta-regression procedure was only performed when moderator variables were 
Results
Studies included in the meta-analysis
The whole search picture was depicted as figure 1 and supplemental figure S1. In brief, eighty-two articles enter the full-texts investigation stage, and seventy-two were excluded for specific reasons (see supplemental table S2 ). Finally, ten articles met our inclusion criteria Cerejeira et al., 2013; Chu et al., 2016; Cinar et al., 2014; Egberts et al., 2015; Lemstra et al., 2008; Morandi et al., 2011; Shen, Shao, Chen, & Guo, 2016; Wilson et al., 2005; Yen et al., 2016) . Peripheral levels of IGF-1 were obtained before delirium occurring in the seven studies (Cerejeira et al., 2013; Chu et al., 2016; Cinar et al., 2014; Lemstra et al., 2008; Shen et al., 2016; Wilson et al., 2005; Yen et al., 2016) . The participants in other three studies might be drawn IGF-1during delirious status Egberts et al., 2015; Morandi et al., 2011) .
Methodological quality assessment
The mean modified NOS score was 7.4 with standard deviation (SD) = 0.5 across 3 4 5 6 7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 14 the ten studies. The score in each domain of the modified NOS is shown in supplemental table S3.
The main results of the meta-analysis comparing the levels of IGF-1 in patients with delirium and those without delirium
Our systematic review and meta-analysis included 10 articles that met our inclusion criteria. Peripheral (serum or plasma) IGF-1 levels were measured in these ten studies.
The quantitative determination of IGF-1 were taken from plasma (Cerejeira et al., 2013; Wilson et al., 2005) and serum Chu et al., 2016; Cinar et al., 2014; Egberts et al., 2015; Morandi et al., 2011; Shen et al., 2016; Yen et al., 2016) , respectively. One study (Lemstra et al., 2008 ) mentioned that IGF-1 was assessed from blood sample (table 1). We found 294 delirious patients (mean age 73.0 years, women 51.0 %) and 604 non-delirious patients (mean age 76.9 years, women 53.2 %) among the 10 studies. Peripheral levels of IGF-1 in patients with delirium were significantly lower than in those without delirium (Hedges' g = -0.209, 95% 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 15
Sensitivity test
The significant result of current meta-analysis became non-significant after 
Meta-regression
There was no any significant association between the differences of peripheral IGF-1 and clinical variables, including percentage of cognitive impairment (p=0.960), mean age (p=0.978), female proportion (p=0.721), mean MMSE scores (p=0.929), or quality of methodology as total modified NOS scores (p=0.270).
Discussion
To the best of our knowledge, the study is the first meta-analysis to address the association between peripheral IGF-1 and delirium and suggests that lower peripheral IGF-1 levels were found in patients with delirium compared with those without 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 16 delirium. Although causality of delirium and peripheral levels of IGF-1 has yet to be clarified, our study offers additional evidence supporting the immune-inflammatory hypothesis in delirium.
The link between delirium and peripheral levels of IGF-1 can be mediated by cytokines released during inflammatory processes. Reportedly, a strong correlation is seen to exist between delirium and inflammation (Broadhurst & Wilson, 2001 ).
Peripheral IGF-1 can cross the blood-brain barrier and play a role in neuronal function (Reinhardt & Bondy, 1994) . It has been reported that administration of IGF-1 reduces secondary neuronal loss after transient neural injuries (Gluckman et al., 1998; Trejo, Carro, Garcia-Galloway, & Torres-Aleman, 2004) . Similarly, replacement therapy with IGF-1 ameliorates diabetic neuropathy (Schmidt et al., 1999) . Our study provides additional evidence to support this hypothesis. Lower peripheral levels of IGF-1 may possess lesser neuroprotective properties that is anti-apoptotic and anti-inflammatory actions, and contributed higher risk of delirium.
Another factor involved in the connection between peripheral levels of IGF-1 and delirium may be relatively high mean age (almost above 70 years old) of participants in the included studies. Ageing, resulting from increased natural immunity activity, is a low level inflammatory status (Godbout & Johnson, 2009; Licastro et al., 2005) . 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 17 Inflammation is related to several morbid conditions in the elderly such as cardiovascular disease (Pai et al., 2004) or Alzheimer's disease (Casserly & Topol, 2004) . Furthermore, inflammation may result in the breakdown of the blood-brain barrier (Jeppsson et al., 1981) and decrease cholinergic transfer (Hammond, Meador, Aung-Din, & Wilder, 1987) . Taken together, elevated levels of proinflammatory cytokine levels have been suggested to predispose the development of delirium in elderly, which is interpreted by the concept of immunosenescence (Godbout & Johnson, 2006) . IGF-1, involving neuro-inflammation in the CNS (Trejo et al., 2004) , may be also affected by ageing, be associated with delirium. However, our meta-regression showed that mean age did not significantly involve the relation between delirium and IGF-1. In addition to limited case numbers, relatively narrowing distribution of mean age may also restrict the statistical significance.
Previous study also indicated that older patients undergoing cardiovascular surgery may develop delirium easily (Cinar et al., 2014) . However, clearly more research is required to better understand this issue.
It has been reported that IGF-1 levels positively correlate with cognitive performance in healthy elderly subjects (Al-Delaimy et al., 2009; Aleman et al., 2000) .
A meta-analysis has reported a significantly positive correlation between IGF-I and cognition in a healthy elderly population (Arwert, Deijen, & Drent, 2005) . Another 18 study concluded that the IGFI levels showed an inverse correlation with cognitive dysfunction (Murialdo et al., 2001) . In the present meta-analysis study, only two studies enrolled participants with baseline cognitive healthy, which was defined as an MMSE score of ≧ 24 or excluded when enrollment, and reported that lower peripheral levels of IGF-1 associated with incident of delirium in one study (adjusted Cerejeira et al., 2013; Chu et al., 2016; Cinar et al., 2014; Egberts et al., 2015; Lemstra et al., 2008; Morandi et al., 2011; Wilson et al., 2005) studies showed no significant differences between peripheral levels of IGF-1 and delirium. Therefore, cognitive impairment could be a possible confounder unfavorably affecting the association between delirium and peripheral levels of IGF-1.
However, our meta-regression showed that baseline MMSE scores were not significantly linked to a correlation between delirium and IGF-1. This difference may be due to variable statistical methodology between dichotomous grouping [normal cognition vs. mild cognitive impairment (MCI) or dementia] and continuous variables of baseline MMSE scores. The fact that a limited number of cases were studied might 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 19 contribute to the insignificance observed with respect to baseline MMSE scores.
Furthermore, some studies report that IGF-I levels were unaltered or increased among dementia patients (Nasman et al., 1995; Sara et al., 1982; Tham et al., 1993) . A greater number of studies will need to be performed in future to investigate the correlation between cognition and IGF-1 to explore this inconsistency.
Limitations of our study that need to be addressed are: 1) Studying a limited number of cases might be a confounding factor impacting the significance of outcomes. 2) Higher mean age would restrict the application of our findings to younger adults or adolescents. 3) We could not perform subgroup analyses comparing IGF-1 levels in different delirious classifications or diagnostic criteria (hypoactive vs hyperactive delirium and only CAM vs CAM plus DSM-III or -IV diagnosis) due to not enough studies. Future research is required to understand if this influences the relationship observed. 4) Peripheral levels of IGF-1 do not actually reflect the brain levels, and thus the pathogenesis between CNS levels of IGF-1and incident delirium need to be addressed in future studies.
Conclusion
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